Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Report on Extraordinary General Meeting of NeuroSearch A/S

Posted on: 14 Sep 18

14 September 2018

At the company’s Extraordinary General Meeting held today, the following resolution was passed:

Morten Mathiesen and Mikkel Primdal Kæregaard were elected to the Board of Directors. Karin Garre and Christian Lundgren resigned.

After the General Meeting the Board of Directors has elected Mikkel Primdal Kæregaard as chairman and Morten Mathiesen as vice chairman. The Board of Directors thus consists of Mikkel Primdal Kæregaard (chairman), Morten Mathiesen (vice chairman) and Allan Andersen.

Allan Andersen

Allan Andersen, CEO, mobile phone +45 4016 3864.

About NeuroSearch
NeuroSearch A/S (NEUR) is listed on Nasdaq Copenhagen A/S.



Last updated on: 14/09/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.